IMAC (NASDAQ:BACK – Get Free Report) will be releasing its earnings data on Friday, March 29th.
IMAC Trading Up 27.1 %
Shares of IMAC stock opened at $3.05 on Thursday. The business has a 50-day moving average price of $1.79 and a two-hundred day moving average price of $1.87. IMAC has a 1-year low of $1.22 and a 1-year high of $10.62. The company has a market cap of $3.48 million, a P/E ratio of -0.22 and a beta of 0.11.
Institutional Trading of IMAC
An institutional investor recently bought a new position in IMAC stock. Moneta Group Investment Advisors LLC purchased a new position in shares of IMAC Holdings, Inc. (NASDAQ:BACK – Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 16,180,451 shares of the company’s stock, valued at approximately $3,228,000. Moneta Group Investment Advisors LLC owned 59.29% of IMAC at the end of the most recent quarter. 5.84% of the stock is owned by institutional investors and hedge funds.
IMAC Company Profile
IMAC Holdings, Inc owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains.
Featured Articles
- Five stocks we like better than IMAC
- Transportation Stocks Investing
- Best Bear Market Funds: Top 3 Investment Options to Consider
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Is DraftKings A Good Bet Ahead of Q1 Earnings?
- How Can Investors Benefit From After-Hours Trading
- Mid-Cap Stocks to Outperform the Market This Cycle
Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.